Zhu J - Search Results

1

Microenvironment of a tumor-organoid system enhances hepatocellular carcinoma malignancy-related hallmarks.

Wang Y, Takeishi K, Li Z, Cervantes-Alvarez E, Collin de l'Hortet A, Guzman-Lepe J, Cui X, Zhu J. Wang Y, et al. Among authors: zhu j. Organogenesis. 2017 Jul 3;13(3):83-94. doi: 10.1080/15476278.2017.1322243. Epub 2017 May 26. Organogenesis. 2017. PMID: 28548903 Free PMC article.

2

[Management of hepatic artery related complications and its outcome during liver transplantation].

Li Z, Li GM, Huang L, Wang D, Gao J, Gao PJ, Leng XS, Zhu JY. Li Z, et al. Among authors: zhu jy. Beijing Da Xue Xue Bao Yi Xue Ban. 2010 Dec 18;42(6):650-3. Beijing Da Xue Xue Bao Yi Xue Ban. 2010. PMID: 21170094 Free article. Chinese.

3

Efficacy of sorafenib after liver transplantation in patients with primary hepatic carcinoma exceeding the Milan criteria: a preliminary study.

Huang L, Li GM, Zhu JY, Li Z, Li T, Leng XS. Huang L, et al. Onco Targets Ther. 2012;5:457-62. doi: 10.2147/OTT.S31387. Epub 2012 Dec 20. Onco Targets Ther. 2012. PMID: 23277740 Free PMC article.

4

Histological differentiation predicts post-liver transplantation survival time.

Li WX, Li Z, Gao PJ, Gao J, Zhu JY. Li WX, et al. Among authors: zhu jy. Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):201-8. doi: 10.1016/j.clinre.2013.11.002. Epub 2013 Dec 30. Clin Res Hepatol Gastroenterol. 2014. PMID: 24388339

5

Ex vivo converted double negative T cells suppress activated B cells.

Li W, Tian Y, Li Z, Gao J, Shi W, Zhu J, Zhang D. Li W, et al. Among authors: zhu j. Int Immunopharmacol. 2014 May;20(1):164-9. doi: 10.1016/j.intimp.2014.02.034. Epub 2014 Mar 7. Int Immunopharmacol. 2014. PMID: 24613134

6

Hepatocellular carcinoma recurrence is an independent risk factor for HB recurrence after liver transplantation.

Gao PJ, Gao J, Li Z, Hu ZP, Zhu JY. Gao PJ, et al. Among authors: zhu jy. Hepatogastroenterology. 2014 Sep;61(134):1523-8. Hepatogastroenterology. 2014. PMID: 25436336

7

De novo malignancy after liver transplantation: a single-center experience of 14 cases.

Gao PJ, Gao J, Li Z, Hu ZP, Zhu JY. Gao PJ, et al. Among authors: zhu jy. Ann Surg Treat Res. 2015 Apr;88(4):222-8. doi: 10.4174/astr.2015.88.4.222. Epub 2015 Mar 26. Ann Surg Treat Res. 2015. PMID: 25844357 Free PMC article.

8

Prognostic value of glypican-3 in patients with HBV-associated hepatocellular carcinoma after liver transplantation.

Cui X, Li Z, Gao PJ, Gao J, Zhu JY. Cui X, et al. Among authors: zhu jy. Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):157-63. doi: 10.1016/s1499-3872(15)60349-6. Hepatobiliary Pancreat Dis Int. 2015. PMID: 25865688

9

Esophagogastric devascularization without splenectomy in portal hypertension: safe and effective?

Ni YB, Gao PJ, Wang D, Li Z, Zhu JY. Ni YB, et al. Hepatobiliary Pancreat Dis Int. 2015 Jun;14(3):276-80. doi: 10.1016/s1499-3872(15)60328-9. Hepatobiliary Pancreat Dis Int. 2015. PMID: 26063028

10

Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.

Cui X, Hu ZP, Li Z, Gao PJ, Zhu JY. Cui X, et al. World J Gastroenterol. 2015 Jul 28;21(28):8588-604. doi: 10.3748/wjg.v21.i28.8588. World J Gastroenterol. 2015. PMID: 26229401 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42,262 results

Search Page

Filters